Consultant Medical Oncologist
A globally acknowledged cancer consultant, and author of over 400 peer-reviewed publications.
Dr Peter Harper is an accredited physician and a medical oncologist, and one of the four founders of the London Oncology Clinic. His strength is targeting treatment to each patient’s specific needs, and he has dealt with most forms of cancer. He is particularly in demand from men seeking help with tumours of the prostate, kidney, testes and bladder.
Dr Harper is acknowledged globally for his work in developing new cancer drugs and treatments. He served on the Board of the French National Cancer Institute (INCA) and was awarded the title of Chevalier Legion D’Honneur in 2003 for his role in advising the French Government in the strategic changes made to their cancer care. In 2004, Dr Harper was awarded the prestigious Cine del Luca Medal in recognition of his work in the development of cancer treatments in lung cancer and gynaecological cancer.
He has previously served on the Board of the International Association for the Study of Lung Cancer (IASLC), the Board of ICACT and remains Secretary to ICACT. He is Chairman elect of the International Advisory Committee of the American Society of Clinical Oncology (ASCO) and has previously served on the Board of the International Gynecological Cancer Group (IGCS). He is an honorary member of cancer societies in Denmark, Malaysia and Thailand and is a founder and Previous board member of the Society International Oncologae Geriatrica (SIOG). He has recently represented the British Government at UK Health Meetings in Delhi and Shanghai (2015).
Dr Harper has been a member, executive member and chair of major UK medical committees, including numerous working parties at the UK Medical Research Council and trial committees at the UK Coordinating Committee of Cancer Research. He acts on advisory boards for new anticancer and vaccine therapy for seven industry leaders. Dr Harper is also a member of numerous professional bodies including the Royal Society of Medicine, British Association of Cancer Research and a founder member of both the London Lung Group and the London Gynaecology Oncology Group.
Dr Harper has published over 200 peer review papers, has presented over 300 papers in abstract and has contributed 14 chapters in text books His Cancer Research is now in association with the LOC partner organization Sarah Canon Research Institute (SCRI) HCA's clinical research division, and he is Chairman of their Medical Advisory Committee. He sat on eight editorial boards, including the prestigious “American Journal of Cancer”, and currently “Targeted Oncology” and “The Oncologist”.
Dr Harper trained at University College and University College Hospital. He was appointed Consultant Medical Oncologist to Guy’s Hospital in 1969 as a general physician and medical oncologist, one of the first such post in a NHS hospital. He was subsequently consultant Medical Oncologist at King’s and St Thomas’ Hospital NHS Trust, and at the time of his retirement from NHS work in 2005 was appointed Consultant Emeritus to the Hospitals.
Services provided to HCA
Dr Harper provides medical advisory services for HCA's Leaders in Onclogy Care. In his role, Dr Harper leads interactions with hospital medical staff and the hospital leadership team to assist the hospital by providing medical advice and promote high quality, cost effective care.
In his role, he contributes to the strategy, policies and decision making regarding oncology treatments and advises HCA to ensure that care provided within the facility is appropriate and efficient. In his role, Dr Harper advises on initiatives to drive clinical standards by providing professional advice on clinical governance matters and ensuring the adoption of those by colleagues in the oncology area.
In addition, he works with medical insurance companies, GPs, other relevant local NHS contacts, and patients to educate and advise on relevant clinical updates to treatments in oncology available in the facility. Furthermore, he advises on the accuracy of literature that may be published regarding relevant services. He will also advise on how to make the patient referral smooth to reduce stress and anxiety for patients.
As well as promoting successful working of the facility's Medical Advisory Committee, Integrated Governance Committee and advising the hospital's senior management team on all matters relating to medical practice within the facility, Dr Harper is responsible for providing advice on clinical governance matters to conform with national standards and recommend new programmes to drive up clinical standards.
In addition, he supports the HCA team to recruit and retain staff as well as taking a lead role in coaching and support doctors and medical staff credentialing. In his role, he will evaluate ongoing quality initiatives such as clinical audits and quality assurance programmes.
Dr Harper leads the facility's multi-disciplinary team, bringing together clinical teams, to discuss the quality of care and decide the most appropriate treatment pathways for patients.
He liaises with pharmaceutical boards which helps bring together cutting-edge research and treatments to our patients in partnership with the Sarah Cannon Research Centre, HCA's clinical research division.
HCA UK is charged by doctors in return for their expertise and advice, including on how to operate safe hospital facilities delivering complex care.
All services provided under this agreement are charged to HCA UK. From April to December 2015, the total charge was £17,502. Dr Harper also provides medical advisory services for HCA Healthcare UK. This information can be found here
The information disclosed on this page in accordance with the Private Healthcare Market Investigation Order 2014 is true and accurate to the best of HCA’s knowledge and belief.